CASP9 and lung carcinoma: Knocking down Xb130 with siRNA in thyroid or lung cancer cells reduced cell survival, increased susceptibilities of cells to extrinsic and intrinsic signal-induced cell death, which was associated with increased cleavage of caspase-8 and caspase-9.